Early research (Phase 1)Study completedNCT07691203
What this trial is testing
Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl 25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25 mg/5 mg/1000 mg Extended- Release Tablets
Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Cardiovascular Diseases
Humanis Saglık Anonim Sirketi 36